Extraskeletal Myxoid Chondrosarcoma
📧 Sign up to get email alerts when something new happens for Extraskeletal Myxoid Chondrosarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Testing Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People >= 18 Years Old With Advanced Soft Tissue Sarcoma [Phase 2]
A Phase 2 clinical trial update describes testing the combination of ipilimumab and nivolumab with or without cabozantinib in adults with ad…
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577) [Phase 1, Phase 2]
A rollover protocol update is described to allow continued access to the LSD1 inhibitor seclidemstat (SP-2577) in ongoing Phase 1/Phase 2 tr…
-
CLINICAL_TRIALS trial_result · 2023-03-27Clinical Trial Update: Trial of Pazopanib in Patients With Solitary Fibrous Tumor and Extraskeletal Myxoid Chondrosarcoma [Phase 2]
Phase 2 trial of pazopanib in solitary fibrous tumor and extraskeletal myxoid chondrosarcoma has completed.
-
CLINICAL_TRIALS trial_result · 2018-03-07Clinical Trial Update: A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas [Phase 2]
Phase 2 trial evaluating perifosine in chemo-insensitive sarcomas, including chondrosarcoma, alveolar soft-part sarcoma, and extraskeletal m…